Amyotrophic Lateral Sclerosis (ALS) Gulf War Study
NCT00007722 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135
Last updated 2009-10-09
Summary
Recently, concern has arisen regarding a possible elevated occurrence of ALS among veterans who served in the Persian Gulf during Operations Desert Shield (August 2, 1990 - January 15, 1991), Desert Storm (January 16, 1991 - February 28, 1991) and Clean-up (March 1, 1991 - July 31, 1991). This study involves an epidemiologic investigation into the occurrence of ALS among veterans of the Gulf War. This study will further define the epidemiology of this neurological disease among younger individuals while determining whether there is a higher than expected occurrence. It will also ascertain the etiologic importance of deployment to the Persian Gulf and exposure to specific environmental factors in that geographic area. VA is leading this joint federal government epidemiologic study that also involves DoD, HHS, CDC, and academic centers of excellence in neurology, with advice from the ALS Association.
Conditions
Sponsors & Collaborators
-
United States Department of Defense
collaborator FED -
Centers for Disease Control and Prevention
collaborator FED -
Department of Health and Human Services
collaborator FED -
ALS Association
collaborator OTHER -
US Department of Veterans Affairs
lead FED
Principal Investigators
-
Eugene Z. Oddone, MD MHSc · VA Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-07-31
- Primary Completion
- 2003-03-31
- Completion
- 2003-03-31
Countries
- United States
Study Locations
More Related Trials
-
Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients
NCT02424669 ·Status: UNKNOWN ·Phase: NA
-
Ultra-high-caloric, Fatty Diet in ALS
NCT06280079 ·Status: RECRUITING ·Phase: NA
-
Determining the Safety of L-serine in ALS
NCT01835782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Influence of the Vitamin D Blood Levels on the Amyotrophic Lateral Sclerosis Phenotype
NCT01823380 ·Status: COMPLETED ·Phase: NA
-
Multiple Doses of AT-1501-A201 in Adults With ALS
NCT04322149 ·Status: COMPLETED ·Phase: PHASE2
-
Exogenous Toxicants and Genetic Susceptibility in ALS
NCT00011154 ·Status: COMPLETED
-
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
NCT01521728 ·Status: COMPLETED ·Phase: NA
-
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
NCT04008329 ·Status: RECRUITING
-
Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)
NCT03366506 ·Status: RECRUITING
-
The National Amyotrophic Lateral Sclerosis Registry
NCT01772602 ·Status: RECRUITING
-
Oral Nutritional Supplementation in Amyotrophic Lateral Sclerosis (ALS) Patients
NCT02152449 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT01378676 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry
NCT04559009 ·Status: COMPLETED
-
Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis
NCT00339976 ·Status: COMPLETED
-
Hyperlipidemia and Statin Therapy in Amyotrophic Lateral Sclerosis
NCT01592084 ·Status: COMPLETED
-
Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS
NCT03520517 ·Status: COMPLETED ·Phase: PHASE1
-
Metagenomic Characterization of the Intestinal Microbiota in ALS Patients and Association With Clinical Phenotypes
NCT06771414 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety of Plasma Exchange With Albutein® 5% in Participants With Amyotrophic Lateral Sclerosis
NCT02872142 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
NCT00748501 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis
NCT00069186 ·Status: UNKNOWN ·Phase: PHASE3
-
ALS Research Collaborative
NCT06885918 ·Status: RECRUITING
-
Methodology Study of Novel Outcome Measures to Assess Progression of ALS
NCT02611674 ·Status: COMPLETED
-
Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD
NCT04220021 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT07082192 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS)
NCT01091142 ·Status: COMPLETED ·Phase: PHASE1